Neratinib
Last Updated: 06/30/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 665 publications
Treatment Effect Reanalysis of the Randomized Individual Screening Trial of Innovative Glioblastoma Therapy in Newly Diagnosed Glioblastoma With External Control Data.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: May 22, 2026
Long-term cardiotoxicity outcomes of trastuzumab and cardiac safety of novel HER2-targeted therapies.
Journal: Expert opinion on drug safety
Published: May 04, 2026
Integrative multi-omic analysis identified ERBB2 mutations and senescence-driven immune suppression as dual therapeutic targets in LAR triple-negative breast cancer.
Journal: Cancer biology & medicine
Published: April 13, 2026
Identification of small-molecule inhibitors targeting HER2 for breast cancer therapy using structure-based virtual screening, ADMET profiling, and molecular dynamics simulations.
Journal: Cellular and molecular biology (Noisy-le-Grand, France)
Published: March 16, 2026
Novel benzimidazole-based thioamide derivatives as potential anticancer agents: synthesis, biological evaluation, and in silico studies.
Journal: Bioorganic chemistry
Published: February 21, 2026
Real-world use of neratinib as extended adjuvant therapy in HER2-positive early-stage breast cancer: a multicentre study in mainland China and Hong Kong.
Journal: Breast (Edinburgh, Scotland)
Published: February 06, 2026
Identification of MMP14 and FOS as key regulators of vascular smooth muscle cell senescence in diabetic kidney disease: A combined bioinformatics and experimental study.
Journal: Archives of gerontology and geriatrics
Published: February 04, 2026
Metastatic Fibrolamellar Hepatocellular Carcinoma in a Young Adult: A Case Report and Narrative Review.
Journal: Journal of hepatocellular carcinoma
Published: February 03, 2026
Management of HER2+ Breast Cancer with and without Brain Metastases in Saudi Arabia: Literature Insights and an Expert Survey of Current Practices.
Journal: Breast cancer (Dove Medical Press)
Published: January 27, 2026
Neratinib, a Clinical Drug Treating Breast Cancer, Protects Against Vascular Inflammation and Atherosclerosis.
Journal: Circulation research
Published: January 09, 2026
Enhanced Payload Release Enables Disitamab Vedotin to Surpass Trastuzumab Emtansine and Retain Efficacy in Acquired Resistance to Clinical Anti-HER2 Therapies.
Journal: Pharmaceutics
Published: December 18, 2025
Last Updated: 06/30/2026